Skip to main content
. 2020 Nov 9;10:391. doi: 10.1038/s41398-020-01080-1

Fig. 3. Common dysregulation in the uptake and metabolism of main omega-3 fatty acids and derivatives in retinal abnormalities and early events of schizophrenia.

Fig. 3

Dysregulation in the uptake and metabolism of omega-3 fatty acid docosahexaenoic acid (DHA) and its derivatives in the retina and the brain are associated with retinal abnormalities and early events in the pathogenesis of schizophrenia. Adiponectin receptor 1 (AdipoR1), primarily found in the eye and brain with little expression in other tissues, captures DHA in both the retina and brain. DHA is an important precursor of VLC-PUFAs (32:6n-3 and 34:6n-3), which subsequently turn into elovanoids (ELVs, ELV-N32, and ELV-N34) catalyzed by the elongase enzyme, specifically through the elongation of very-long-chain fatty acids-4 (ELOVL4). In addition, DHA is the precursor of neuroprotectin D1 (NPD1). Both ELVs and NPD1 sustain the integrity of the pigment epithelial cells (PECs) as well as photoreceptor cells (PRCs) in the retina. Dysregulation of DHA uptake and conversion into ELVs and NPD1 can disrupt the structural and functional integrity of the retina, leading to retinal abnormalities. In the brain, NPD1, converted from its precursor DHA, is involved in the protection of dopaminergic circuits. Dysregulation of DHA uptake and its conversion into NPD1 is associated with the loss of dopamine neurons, which is proposed to contribute to the pathogenesis of schizophrenia.